In other cancers, previous studies have demonstrated the association between CD47 protein expression and poor clinicopathological characteristics [28,29,30,31], suggesting the contribution of CD47 in the evasion of cancer cells from immune surveillance. The gene discussed is CD47; the disease is cancer.